NovaMedica is a new kind of pharmaceutical company. Our strategy is to search the world for important new approved products that will help improve the health care of Russians, in addition to the exciting line of pipeline products we will in-license from the portfolio companies of Domain Associates in which our shareholders choose to invest. We will bring these products to Russia and the CIS countries and then market them to Russian/CIS specialty physicians and health care providers better than anyone else. As part of our mission to be a leading provider in Russia and the CIS of innovative specialty pharma products and solutions that treat a range of therapeutic disorders, we will be developing this site over the coming months to provide Russian and CIS healthcare professionals with an assortment of educational and information resources.
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem (World Health Organization).
Please inform us of any adverse events that might be associated with our pharmaceutical products:
· via the hotline: +7 (800) 222-49-08
· by e-mail:
Pharmaceutical safety information is extremely important as it helps ensure that medicinal products are being used in an effective and safe manner.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024